Duearity Investor Relations Material
Latest events
Q2 2024
29 Aug, 2024
Q1 2024
31 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Duearity
Access all reports
Duearity is a Swedish medical technology company that develops solutions for tinnitus treatment. The company focuses on non-invasive, wearable devices that deliver sound therapy to alleviate symptoms. Its products are designed for home use, aiming to improve quality of life for individuals with chronic tinnitus. The company is headquartered in Malmö, Sweden, and its shares are listed on the NGM.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
DEAR
Country
🇸🇪 Sweden